

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glyoxylate metabolic process (GO:0046487) | 9.25389708 |
| 2 | regulation of fibrinolysis (GO:0051917) | 8.32177856 |
| 3 | negative regulation of fibrinolysis (GO:0051918) | 8.10811656 |
| 4 | complement activation, alternative pathway (GO:0006957) | 7.64250001 |
| 5 | negative regulation of cholesterol transport (GO:0032375) | 7.60009966 |
| 6 | negative regulation of sterol transport (GO:0032372) | 7.60009966 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.51075455 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 7.51075455 |
| 9 | regulation of protein activation cascade (GO:2000257) | 7.38558388 |
| 10 | drug catabolic process (GO:0042737) | 7.35053233 |
| 11 | regulation of complement activation (GO:0030449) | 6.92582082 |
| 12 | protein carboxylation (GO:0018214) | 6.89408004 |
| 13 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.89408004 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.88629526 |
| 15 | L-phenylalanine metabolic process (GO:0006558) | 6.88629526 |
| 16 | epoxygenase P450 pathway (GO:0019373) | 6.88554810 |
| 17 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.78510490 |
| 18 | urea metabolic process (GO:0019627) | 6.67428446 |
| 19 | exogenous drug catabolic process (GO:0042738) | 6.59067220 |
| 20 | fibrinolysis (GO:0042730) | 6.48594385 |
| 21 | phospholipid efflux (GO:0033700) | 6.44733558 |
| 22 | urea cycle (GO:0000050) | 6.32929494 |
| 23 | serine family amino acid catabolic process (GO:0009071) | 6.23995969 |
| 24 | omega-hydroxylase P450 pathway (GO:0097267) | 6.13692093 |
| 25 | regulation of triglyceride catabolic process (GO:0010896) | 6.10466043 |
| 26 | nitrogen cycle metabolic process (GO:0071941) | 6.04930239 |
| 27 | blood coagulation, intrinsic pathway (GO:0007597) | 5.99617312 |
| 28 | regulation of plasminogen activation (GO:0010755) | 5.74191117 |
| 29 | regulation of cholesterol esterification (GO:0010872) | 5.71783002 |
| 30 | aromatic amino acid family catabolic process (GO:0009074) | 5.31746832 |
| 31 | protein-lipid complex remodeling (GO:0034368) | 5.29440524 |
| 32 | macromolecular complex remodeling (GO:0034367) | 5.29440524 |
| 33 | plasma lipoprotein particle remodeling (GO:0034369) | 5.29440524 |
| 34 | positive regulation of triglyceride lipase activity (GO:0061365) | 5.25830032 |
| 35 | positive regulation of lipoprotein lipase activity (GO:0051006) | 5.25830032 |
| 36 | drug metabolic process (GO:0017144) | 5.14093990 |
| 37 | cholesterol efflux (GO:0033344) | 5.08577662 |
| 38 | glycine metabolic process (GO:0006544) | 5.08391812 |
| 39 | high-density lipoprotein particle remodeling (GO:0034375) | 5.07698593 |
| 40 | phenylpropanoid metabolic process (GO:0009698) | 5.04204812 |
| 41 | cellular glucuronidation (GO:0052695) | 5.03505162 |
| 42 | negative regulation of hemostasis (GO:1900047) | 4.85808040 |
| 43 | negative regulation of blood coagulation (GO:0030195) | 4.85808040 |
| 44 | oxidative demethylation (GO:0070989) | 4.85272051 |
| 45 | acylglycerol homeostasis (GO:0055090) | 4.83225491 |
| 46 | triglyceride homeostasis (GO:0070328) | 4.83225491 |
| 47 | uronic acid metabolic process (GO:0006063) | 4.81045463 |
| 48 | glucuronate metabolic process (GO:0019585) | 4.81045463 |
| 49 | reverse cholesterol transport (GO:0043691) | 4.80943188 |
| 50 | protein activation cascade (GO:0072376) | 4.77116574 |
| 51 | bile acid biosynthetic process (GO:0006699) | 4.70948702 |
| 52 | regulation of lipoprotein particle clearance (GO:0010984) | 4.70710600 |
| 53 | plasma lipoprotein particle clearance (GO:0034381) | 4.53350289 |
| 54 | positive regulation of blood coagulation (GO:0030194) | 4.52213489 |
| 55 | positive regulation of hemostasis (GO:1900048) | 4.52213489 |
| 56 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.47688279 |
| 57 | bile acid and bile salt transport (GO:0015721) | 4.44144290 |
| 58 | bile acid metabolic process (GO:0008206) | 4.43631720 |
| 59 | negative regulation of coagulation (GO:0050819) | 4.43114454 |
| 60 | intestinal cholesterol absorption (GO:0030299) | 4.41015847 |
| 61 | serine family amino acid metabolic process (GO:0009069) | 4.37104957 |
| 62 | complement activation, classical pathway (GO:0006958) | 4.35106684 |
| 63 | complement activation (GO:0006956) | 4.32471025 |
| 64 | regulation of humoral immune response (GO:0002920) | 4.31593544 |
| 65 | negative regulation of wound healing (GO:0061045) | 4.31259987 |
| 66 | negative regulation of lipase activity (GO:0060192) | 4.30908137 |
| 67 | ethanol oxidation (GO:0006069) | 4.24533785 |
| 68 | proline metabolic process (GO:0006560) | 4.16732246 |
| 69 | positive regulation of coagulation (GO:0050820) | 4.16082015 |
| 70 | negative regulation of protein activation cascade (GO:2000258) | 4.13160559 |
| 71 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 4.06313243 |
| 72 | serine family amino acid biosynthetic process (GO:0009070) | 4.03976336 |
| 73 | arginine metabolic process (GO:0006525) | 4.01991409 |
| 74 | acute-phase response (GO:0006953) | 4.01643598 |
| 75 | plasma lipoprotein particle organization (GO:0071827) | 4.00632947 |
| 76 | plasma lipoprotein particle assembly (GO:0034377) | 3.96634845 |
| 77 | alpha-amino acid catabolic process (GO:1901606) | 3.95873569 |
| 78 | tyrosine metabolic process (GO:0006570) | 3.92368773 |
| 79 | flavonoid metabolic process (GO:0009812) | 3.90391179 |
| 80 | alkaloid metabolic process (GO:0009820) | 3.87713160 |
| 81 | imidazole-containing compound metabolic process (GO:0052803) | 3.83960443 |
| 82 | negative regulation of lipid transport (GO:0032369) | 3.81502809 |
| 83 | hormone catabolic process (GO:0042447) | 3.80949413 |
| 84 | positive regulation of lipid catabolic process (GO:0050996) | 3.76903267 |
| 85 | protein-lipid complex subunit organization (GO:0071825) | 3.75471677 |
| 86 | glutamate metabolic process (GO:0006536) | 3.74824418 |
| 87 | aldehyde catabolic process (GO:0046185) | 3.70794876 |
| 88 | cysteine metabolic process (GO:0006534) | 3.68397438 |
| 89 | regulation of apoptotic cell clearance (GO:2000425) | 3.67125073 |
| 90 | heme transport (GO:0015886) | 3.62718197 |
| 91 | arginine catabolic process (GO:0006527) | 3.62549258 |
| 92 | low-density lipoprotein particle remodeling (GO:0034374) | 3.61481686 |
| 93 | negative regulation of complement activation (GO:0045916) | 3.59518950 |
| 94 | drug transmembrane transport (GO:0006855) | 3.56696313 |
| 95 | cellular ketone body metabolic process (GO:0046950) | 3.56106605 |
| 96 | sulfur amino acid catabolic process (GO:0000098) | 3.54244020 |
| 97 | L-serine metabolic process (GO:0006563) | 3.53337870 |
| 98 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.52767637 |
| 99 | protein-lipid complex assembly (GO:0065005) | 3.50950083 |
| 100 | ethanol metabolic process (GO:0006067) | 3.48522509 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.34587246 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.86995880 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.04828402 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.58810772 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.91394167 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.50290442 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.15336264 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.06604594 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.85815658 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.34367696 |
| 11 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.33924984 |
| 12 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.25701575 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.00923756 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.2676563 |
| 15 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.85077109 |
| 16 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.83946209 |
| 17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.67396461 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.60824827 |
| 19 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.55007656 |
| 20 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.46564533 |
| 21 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.45026819 |
| 22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38216938 |
| 23 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.37698549 |
| 24 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.23617574 |
| 25 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.15643433 |
| 26 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.13100945 |
| 27 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.12130119 |
| 28 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.01729053 |
| 29 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01138310 |
| 30 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98341259 |
| 31 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.97068710 |
| 32 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.96789847 |
| 33 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.89047808 |
| 34 | GATA1_22025678_ChIP-Seq_K562_Human | 0.88891246 |
| 35 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.87514926 |
| 36 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.87472430 |
| 37 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.86997310 |
| 38 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.86240736 |
| 39 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.85126640 |
| 40 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.84658161 |
| 41 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.83244654 |
| 42 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.83211716 |
| 43 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.81228974 |
| 44 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80501209 |
| 45 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.80370800 |
| 46 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80337975 |
| 47 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.78135197 |
| 48 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.75409450 |
| 49 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.74814419 |
| 50 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.74555979 |
| 51 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.74234334 |
| 52 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.74004527 |
| 53 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.73816289 |
| 54 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.70197508 |
| 55 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.70055455 |
| 56 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.69133205 |
| 57 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.68937839 |
| 58 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.68647001 |
| 59 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.68525348 |
| 60 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.68483166 |
| 61 | NFYA_21822215_ChIP-Seq_K562_Human | 0.68257889 |
| 62 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.67707798 |
| 63 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.67261894 |
| 64 | SA1_27219007_Chip-Seq_Bcells_Human | 0.67226578 |
| 65 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.66111016 |
| 66 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.65678984 |
| 67 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.65042690 |
| 68 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.65002402 |
| 69 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.64466578 |
| 70 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.64443068 |
| 71 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.64297746 |
| 72 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.63670127 |
| 73 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.63277107 |
| 74 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.63000175 |
| 75 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.62946118 |
| 76 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.62557294 |
| 77 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.62547821 |
| 78 | AR_20517297_ChIP-Seq_VCAP_Human | 0.62263943 |
| 79 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.60931237 |
| 80 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.60583062 |
| 81 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59877341 |
| 82 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.59660694 |
| 83 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.58131898 |
| 84 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.56959676 |
| 85 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.56828582 |
| 86 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.56306827 |
| 87 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.56205991 |
| 88 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.55345427 |
| 89 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.55338204 |
| 90 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.55183232 |
| 91 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.54912229 |
| 92 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.54775296 |
| 93 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.54452846 |
| 94 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.53097176 |
| 95 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.51566507 |
| 96 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.51472257 |
| 97 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.51003149 |
| 98 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.50888194 |
| 99 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.50154548 |
| 100 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.49525860 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 9.63915361 |
| 2 | MP0005360_urolithiasis | 7.26569091 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.94793777 |
| 4 | MP0003195_calcinosis | 5.84283036 |
| 5 | MP0002138_abnormal_hepatobiliary_system | 5.44509046 |
| 6 | MP0005365_abnormal_bile_salt | 5.10993309 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.89864933 |
| 8 | MP0003252_abnormal_bile_duct | 3.60189894 |
| 9 | MP0003868_abnormal_feces_composition | 3.33394361 |
| 10 | MP0001666_abnormal_nutrient_absorption | 3.18785563 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.92614796 |
| 12 | MP0009840_abnormal_foam_cell | 2.77675767 |
| 13 | MP0009697_abnormal_copulation | 2.76884764 |
| 14 | MP0002876_abnormal_thyroid_physiology | 2.64065633 |
| 15 | MP0005332_abnormal_amino_acid | 2.51466640 |
| 16 | MP0003806_abnormal_nucleotide_metabolis | 1.84432984 |
| 17 | MP0001764_abnormal_homeostasis | 1.76783904 |
| 18 | MP0000609_abnormal_liver_physiology | 1.71569860 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 1.65046013 |
| 20 | MP0005083_abnormal_biliary_tract | 1.59621895 |
| 21 | MP0010368_abnormal_lymphatic_system | 1.53436515 |
| 22 | MP0004019_abnormal_vitamin_homeostasis | 1.46306141 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 1.39403905 |
| 24 | MP0005408_hypopigmentation | 1.35230217 |
| 25 | MP0005319_abnormal_enzyme/_coenzyme | 1.18676298 |
| 26 | MP0001661_extended_life_span | 1.18131939 |
| 27 | MP0005451_abnormal_body_composition | 1.18115627 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.07835523 |
| 29 | MP0002132_abnormal_respiratory_system | 1.03850863 |
| 30 | MP0000598_abnormal_liver_morphology | 1.02564114 |
| 31 | MP0009053_abnormal_anal_canal | 0.91967372 |
| 32 | MP0001915_intracranial_hemorrhage | 0.91750878 |
| 33 | MP0000604_amyloidosis | 0.91468209 |
| 34 | MP0005084_abnormal_gallbladder_morpholo | 0.91116547 |
| 35 | MP0002971_abnormal_brown_adipose | 0.90615819 |
| 36 | MP0005187_abnormal_penis_morphology | 0.86917249 |
| 37 | MP0002928_abnormal_bile_duct | 0.86223756 |
| 38 | MP0003879_abnormal_hair_cell | 0.84233818 |
| 39 | MP0003690_abnormal_glial_cell | 0.84150843 |
| 40 | MP0005376_homeostasis/metabolism_phenot | 0.83986246 |
| 41 | MP0003186_abnormal_redox_activity | 0.83759575 |
| 42 | MP0005058_abnormal_lysosome_morphology | 0.83300022 |
| 43 | MP0009642_abnormal_blood_homeostasis | 0.83290989 |
| 44 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.81631193 |
| 45 | MP0008469_abnormal_protein_level | 0.77514382 |
| 46 | MP0003638_abnormal_response/metabolism_ | 0.76910541 |
| 47 | MP0003011_delayed_dark_adaptation | 0.76550419 |
| 48 | MP0002168_other_aberrant_phenotype | 0.75736077 |
| 49 | MP0005395_other_phenotype | 0.73015050 |
| 50 | MP0003656_abnormal_erythrocyte_physiolo | 0.72714995 |
| 51 | MP0005636_abnormal_mineral_homeostasis | 0.69982052 |
| 52 | MP0000566_synostosis | 0.59300039 |
| 53 | MP0002078_abnormal_glucose_homeostasis | 0.58756103 |
| 54 | MP0005220_abnormal_exocrine_pancreas | 0.57458312 |
| 55 | MP0009763_increased_sensitivity_to | 0.56404552 |
| 56 | MP0005334_abnormal_fat_pad | 0.55592722 |
| 57 | MP0005464_abnormal_platelet_physiology | 0.55109070 |
| 58 | MP0005670_abnormal_white_adipose | 0.53931148 |
| 59 | MP0002282_abnormal_trachea_morphology | 0.53889947 |
| 60 | MP0004883_abnormal_blood_vessel | 0.49849140 |
| 61 | MP0005448_abnormal_energy_balance | 0.49345322 |
| 62 | MP0002249_abnormal_larynx_morphology | 0.47902651 |
| 63 | MP0005266_abnormal_metabolism | 0.46526967 |
| 64 | MP0000249_abnormal_blood_vessel | 0.45211714 |
| 65 | MP0003075_altered_response_to | 0.44757342 |
| 66 | MP0005164_abnormal_response_to | 0.44746689 |
| 67 | MP0002089_abnormal_postnatal_growth/wei | 0.44138148 |
| 68 | MP0005535_abnormal_body_temperature | 0.42644583 |
| 69 | MP0010386_abnormal_urinary_bladder | 0.40387553 |
| 70 | MP0009764_decreased_sensitivity_to | 0.40213777 |
| 71 | MP0009115_abnormal_fat_cell | 0.39714989 |
| 72 | MP0003953_abnormal_hormone_level | 0.39543648 |
| 73 | MP0004272_abnormal_basement_membrane | 0.39306631 |
| 74 | MP0003329_amyloid_beta_deposits | 0.37299054 |
| 75 | MP0005023_abnormal_wound_healing | 0.36109691 |
| 76 | MP0005166_decreased_susceptibility_to | 0.35739348 |
| 77 | MP0008874_decreased_physiological_sensi | 0.35163080 |
| 78 | MP0002136_abnormal_kidney_physiology | 0.35119816 |
| 79 | MP0001756_abnormal_urination | 0.32885848 |
| 80 | MP0003943_abnormal_hepatobiliary_system | 0.32800611 |
| 81 | MP0004130_abnormal_muscle_cell | 0.31897787 |
| 82 | MP0005379_endocrine/exocrine_gland_phen | 0.31704223 |
| 83 | MP0002970_abnormal_white_adipose | 0.30428737 |
| 84 | MP0002909_abnormal_adrenal_gland | 0.30074907 |
| 85 | MP0003959_abnormal_lean_body | 0.29237129 |
| 86 | MP0004782_abnormal_surfactant_physiolog | 0.29069576 |
| 87 | MP0006036_abnormal_mitochondrial_physio | 0.28681547 |
| 88 | MP0003718_maternal_effect | 0.27190634 |
| 89 | MP0005646_abnormal_pituitary_gland | 0.26585086 |
| 90 | MP0000639_abnormal_adrenal_gland | 0.24738211 |
| 91 | MP0009785_altered_susceptibility_to | 0.24238558 |
| 92 | MP0001944_abnormal_pancreas_morphology | 0.23977519 |
| 93 | MP0003632_abnormal_nervous_system | 0.23776696 |
| 94 | MP0005197_abnormal_uvea_morphology | 0.22859754 |
| 95 | MP0000920_abnormal_myelination | 0.21431959 |
| 96 | MP0008872_abnormal_physiological_respon | 0.20397974 |
| 97 | MP0002822_catalepsy | 0.20258396 |
| 98 | MP0005167_abnormal_blood-brain_barrier | 0.19951016 |
| 99 | MP0003183_abnormal_peptide_metabolism | 0.19662368 |
| 100 | MP0001845_abnormal_inflammatory_respons | 0.18858932 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged partial thromboplastin time (HP:0003645) | 9.02141755 |
| 2 | Complement deficiency (HP:0004431) | 8.31189474 |
| 3 | Hypobetalipoproteinemia (HP:0003563) | 7.05671440 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.05003682 |
| 5 | Joint hemorrhage (HP:0005261) | 6.73161876 |
| 6 | Abnormality of complement system (HP:0005339) | 6.54242162 |
| 7 | Abnormality of pyrimidine metabolism (HP:0004353) | 6.36585061 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 6.18745597 |
| 9 | Xanthomatosis (HP:0000991) | 6.10630502 |
| 10 | Glomerulonephritis (HP:0000099) | 5.23163264 |
| 11 | Intrahepatic cholestasis (HP:0001406) | 4.92851742 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 4.87238606 |
| 13 | Conjugated hyperbilirubinemia (HP:0002908) | 4.36682782 |
| 14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.31611303 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 4.17114383 |
| 16 | Hypolipoproteinemia (HP:0010981) | 4.10243861 |
| 17 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.75082417 |
| 18 | Abnormality of the intrinsic pathway (HP:0010989) | 3.63169665 |
| 19 | Nephritis (HP:0000123) | 3.61190480 |
| 20 | Abnormal gallbladder physiology (HP:0012438) | 3.59977924 |
| 21 | Cholecystitis (HP:0001082) | 3.59977924 |
| 22 | Hypercholesterolemia (HP:0003124) | 3.49756385 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.37950625 |
| 24 | Spontaneous abortion (HP:0005268) | 3.33744140 |
| 25 | Menorrhagia (HP:0000132) | 3.30554098 |
| 26 | Delayed CNS myelination (HP:0002188) | 3.24798911 |
| 27 | Vascular calcification (HP:0004934) | 3.22512871 |
| 28 | Abnormality of nucleobase metabolism (HP:0010932) | 3.21282119 |
| 29 | Hyperammonemia (HP:0001987) | 3.19636390 |
| 30 | Hemorrhage of the eye (HP:0011885) | 3.17971514 |
| 31 | Mitral stenosis (HP:0001718) | 3.14320744 |
| 32 | Hyperglycinemia (HP:0002154) | 3.02917792 |
| 33 | Hypoalphalipoproteinemia (HP:0003233) | 2.99626921 |
| 34 | Fat malabsorption (HP:0002630) | 2.96004867 |
| 35 | Abnormality of glycine metabolism (HP:0010895) | 2.91288253 |
| 36 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.91288253 |
| 37 | Cardiovascular calcification (HP:0011915) | 2.86691453 |
| 38 | Generalized aminoaciduria (HP:0002909) | 2.81112375 |
| 39 | Gingival bleeding (HP:0000225) | 2.77919220 |
| 40 | Reduced antithrombin III activity (HP:0001976) | 2.77608570 |
| 41 | Rickets (HP:0002748) | 2.77543773 |
| 42 | Osteomalacia (HP:0002749) | 2.71147414 |
| 43 | Purpura (HP:0000979) | 2.69473637 |
| 44 | Hyperglycinuria (HP:0003108) | 2.63750014 |
| 45 | Abnormality of the Achilles tendon (HP:0005109) | 2.52724114 |
| 46 | Epidermoid cyst (HP:0200040) | 2.47176807 |
| 47 | Abnormality of methionine metabolism (HP:0010901) | 2.46810761 |
| 48 | Cholelithiasis (HP:0001081) | 2.42455151 |
| 49 | Abnormality of serum amino acid levels (HP:0003112) | 2.42294764 |
| 50 | Arthropathy (HP:0003040) | 2.42026188 |
| 51 | Pulmonary embolism (HP:0002204) | 2.41236946 |
| 52 | Steatorrhea (HP:0002570) | 2.38455853 |
| 53 | Abnormality of proline metabolism (HP:0010907) | 2.34769044 |
| 54 | Hydroxyprolinuria (HP:0003080) | 2.34769044 |
| 55 | Thrombophlebitis (HP:0004418) | 2.30918820 |
| 56 | Abnormal gallbladder morphology (HP:0012437) | 2.24101966 |
| 57 | Fair hair (HP:0002286) | 2.17869057 |
| 58 | Hypophosphatemic rickets (HP:0004912) | 2.16989801 |
| 59 | Hepatocellular carcinoma (HP:0001402) | 2.13060532 |
| 60 | Metabolic acidosis (HP:0001942) | 2.12554983 |
| 61 | Elevated alkaline phosphatase (HP:0003155) | 2.11691693 |
| 62 | Myocardial infarction (HP:0001658) | 2.08160186 |
| 63 | Abnormal biliary tract physiology (HP:0012439) | 2.07591075 |
| 64 | Bile duct proliferation (HP:0001408) | 2.07591075 |
| 65 | Hyperbilirubinemia (HP:0002904) | 2.01637693 |
| 66 | Deep venous thrombosis (HP:0002625) | 11.1058221 |
| 67 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 10.2538519 |
| 68 | Hyperphosphaturia (HP:0003109) | 1.99967453 |
| 69 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.98856228 |
| 70 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.95565484 |
| 71 | Neonatal hypoglycemia (HP:0001998) | 1.94177399 |
| 72 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.93449393 |
| 73 | Irritability (HP:0000737) | 1.92265039 |
| 74 | Gangrene (HP:0100758) | 1.91714939 |
| 75 | Pancreatitis (HP:0001733) | 1.88938413 |
| 76 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.88499784 |
| 77 | Atrioventricular block (HP:0001678) | 1.85003777 |
| 78 | Abnormality of vitamin metabolism (HP:0100508) | 1.82035041 |
| 79 | Abnormality of urine glucose concentration (HP:0011016) | 1.81231115 |
| 80 | Glycosuria (HP:0003076) | 1.81231115 |
| 81 | Reticulocytosis (HP:0001923) | 1.80758853 |
| 82 | Increased mean platelet volume (HP:0011877) | 1.80734493 |
| 83 | Abnormality of purine metabolism (HP:0004352) | 1.76768271 |
| 84 | Poikilocytosis (HP:0004447) | 1.76519189 |
| 85 | Sensorimotor neuropathy (HP:0007141) | 1.75841574 |
| 86 | Enlarged kidneys (HP:0000105) | 1.74019405 |
| 87 | Abnormal urine phosphate concentration (HP:0012599) | 1.70977660 |
| 88 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.68937917 |
| 89 | Ketosis (HP:0001946) | 1.68726517 |
| 90 | Bifid scrotum (HP:0000048) | 1.68365120 |
| 91 | Epistaxis (HP:0000421) | 1.64358392 |
| 92 | Abnormality of the gallbladder (HP:0005264) | 1.64091717 |
| 93 | Hypophosphatemia (HP:0002148) | 1.63273272 |
| 94 | Increased serum ferritin (HP:0003281) | 1.61893829 |
| 95 | Alkalosis (HP:0001948) | 1.61564025 |
| 96 | Abnormal platelet volume (HP:0011876) | 1.61464896 |
| 97 | Mucopolysacchariduria (HP:0008155) | 1.59818003 |
| 98 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.59818003 |
| 99 | Abnormality of carpal bone ossification (HP:0006257) | 1.57937647 |
| 100 | Late onset (HP:0003584) | 1.57496771 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 7.04100135 |
| 2 | PIK3CG | 5.42309135 |
| 3 | FGFR4 | 4.55094912 |
| 4 | TRIB3 | 3.11879232 |
| 5 | SIK1 | 2.75724943 |
| 6 | BCKDK | 2.70013471 |
| 7 | RIPK1 | 2.61001848 |
| 8 | DYRK1B | 2.48036779 |
| 9 | PIK3CA | 2.35456321 |
| 10 | MAP3K3 | 2.08595868 |
| 11 | PRKACG | 2.01421690 |
| 12 | MAPK11 | 1.86643805 |
| 13 | FGFR3 | 1.85181358 |
| 14 | PRKAA2 | 1.61390156 |
| 15 | PDPK1 | 1.58149061 |
| 16 | TBK1 | 1.45870163 |
| 17 | PRKCG | 1.44065752 |
| 18 | MST1R | 1.30057144 |
| 19 | ICK | 1.28383861 |
| 20 | FGFR2 | 1.27187616 |
| 21 | TYK2 | 1.27090978 |
| 22 | MAP2K4 | 1.23540997 |
| 23 | PRPF4B | 1.17607076 |
| 24 | PKN2 | 1.16405414 |
| 25 | PDK1 | 1.15938906 |
| 26 | WNK4 | 1.12963477 |
| 27 | TAOK3 | 1.09239450 |
| 28 | CDK6 | 1.08132032 |
| 29 | MAP2K3 | 1.06453610 |
| 30 | MUSK | 1.06256639 |
| 31 | MAP3K11 | 1.04698885 |
| 32 | NEK9 | 1.00383505 |
| 33 | FRK | 0.96410793 |
| 34 | AKT3 | 0.92735500 |
| 35 | PRKCZ | 0.92151329 |
| 36 | STK38 | 0.90425496 |
| 37 | SGK223 | 0.88746348 |
| 38 | SGK494 | 0.88746348 |
| 39 | BLK | 0.86596400 |
| 40 | JAK1 | 0.83215130 |
| 41 | ABL2 | 0.82272052 |
| 42 | ARAF | 0.81881437 |
| 43 | IGF1R | 0.80224447 |
| 44 | ERBB2 | 0.78580416 |
| 45 | PRKAA1 | 0.77142582 |
| 46 | CSNK1D | 0.76664460 |
| 47 | SGK1 | 0.76191564 |
| 48 | MAP3K12 | 0.74798742 |
| 49 | CDK12 | 0.74553635 |
| 50 | MAP3K2 | 0.74260627 |
| 51 | PRKACA | 0.73351970 |
| 52 | TAOK2 | 0.71638769 |
| 53 | GRK6 | 0.70694155 |
| 54 | MYLK | 0.69064001 |
| 55 | CSF1R | 0.68049430 |
| 56 | NTRK3 | 0.67934790 |
| 57 | CAMK1D | 0.65830275 |
| 58 | PRKG1 | 0.64201676 |
| 59 | CDK4 | 0.63379616 |
| 60 | MET | 0.62411938 |
| 61 | MAP3K1 | 0.58829926 |
| 62 | SGK2 | 0.58322652 |
| 63 | EPHA4 | 0.58136465 |
| 64 | EPHA3 | 0.57513934 |
| 65 | PRKCA | 0.57178743 |
| 66 | CAMKK1 | 0.56404297 |
| 67 | RPS6KA3 | 0.55837440 |
| 68 | RET | 0.55025006 |
| 69 | PDK2 | 0.54984744 |
| 70 | PIM2 | 0.54587056 |
| 71 | GSK3A | 0.52168637 |
| 72 | AKT2 | 0.50136331 |
| 73 | LATS1 | 0.49360489 |
| 74 | SGK3 | 0.49352058 |
| 75 | PDGFRA | 0.48244747 |
| 76 | TGFBR2 | 0.46149590 |
| 77 | JAK2 | 0.45326035 |
| 78 | GRK1 | 0.45080226 |
| 79 | FGFR1 | 0.44736034 |
| 80 | MTOR | 0.43833665 |
| 81 | PRKCB | 0.43484607 |
| 82 | KSR2 | 0.43308173 |
| 83 | EIF2AK1 | 0.42265327 |
| 84 | MAPKAPK3 | 0.41735095 |
| 85 | MAP3K7 | 0.40971903 |
| 86 | IRAK3 | 0.40941754 |
| 87 | MAP3K5 | 0.40091839 |
| 88 | CSNK2A1 | 0.39751826 |
| 89 | CSNK1E | 0.39560376 |
| 90 | SRC | 0.39464727 |
| 91 | MAPK12 | 0.39071130 |
| 92 | INSRR | 0.37953314 |
| 93 | CSNK2A2 | 0.37799200 |
| 94 | MAPK7 | 0.37192306 |
| 95 | PRKACB | 0.36581983 |
| 96 | FER | 0.36154618 |
| 97 | NEK1 | 0.35057289 |
| 98 | CAMK1G | 0.34783499 |
| 99 | TNK2 | 0.34036007 |
| 100 | NLK | 0.33591770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.40883518 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.32322797 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.50859652 |
| 4 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 3.46871031 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.27338950 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.12432225 |
| 7 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.08289633 |
| 8 | * Retinol metabolism_Homo sapiens_hsa00830 | 2.95384727 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.71476018 |
| 10 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.60597801 |
| 11 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.56604480 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.43529667 |
| 13 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.38858594 |
| 14 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.37685714 |
| 15 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.37427240 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.28019824 |
| 17 | * Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.22641844 |
| 18 | Bile secretion_Homo sapiens_hsa04976 | 2.04641971 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.87131145 |
| 20 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.81847959 |
| 21 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.76283972 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.75546821 |
| 23 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.72133710 |
| 24 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.61608745 |
| 25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.60566994 |
| 26 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.60517527 |
| 27 | Peroxisome_Homo sapiens_hsa04146 | 1.53324362 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.51816069 |
| 29 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.50540027 |
| 30 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.49888293 |
| 31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.48097665 |
| 32 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.43491920 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.41323664 |
| 34 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.40086508 |
| 35 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.39411654 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.38705858 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.38575298 |
| 38 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.36000057 |
| 39 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.31961590 |
| 40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.31379073 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.27610282 |
| 42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.11017389 |
| 43 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.10729311 |
| 44 | Prion diseases_Homo sapiens_hsa05020 | 1.06827626 |
| 45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.05990484 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.05020271 |
| 47 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.02447893 |
| 48 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.98671628 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 0.96711558 |
| 50 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91950453 |
| 51 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.83079764 |
| 52 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.82961313 |
| 53 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.81328761 |
| 54 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77655412 |
| 55 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.77322519 |
| 56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.64399653 |
| 57 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.60588107 |
| 58 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.56514972 |
| 59 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.52674475 |
| 60 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.48268632 |
| 61 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.46478720 |
| 62 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.44079388 |
| 63 | Lysine degradation_Homo sapiens_hsa00310 | 0.43347832 |
| 64 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42558836 |
| 65 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.37192603 |
| 66 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36347545 |
| 67 | Pertussis_Homo sapiens_hsa05133 | 0.35312727 |
| 68 | Insulin resistance_Homo sapiens_hsa04931 | 0.33634476 |
| 69 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.31805232 |
| 70 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.24878940 |
| 71 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.22062314 |
| 72 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.21842294 |
| 73 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.21783705 |
| 74 | Other glycan degradation_Homo sapiens_hsa00511 | 0.17856112 |
| 75 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.17190250 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.16585863 |
| 77 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.10460451 |
| 78 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.09138536 |
| 79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.07277157 |
| 80 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.06864616 |
| 81 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.04873750 |
| 82 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.04382003 |
| 83 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.02345578 |
| 84 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.2234741 |
| 85 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1959345 |
| 86 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1774100 |
| 87 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1757621 |
| 88 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1563956 |
| 89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.1440449 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1374820 |
| 91 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1313505 |
| 92 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1061632 |
| 93 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1018742 |
| 94 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0958052 |
| 95 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0658113 |
| 96 | Nitrogen metabolism_Homo sapiens_hsa00910 | -0.0655754 |
| 97 | Selenocompound metabolism_Homo sapiens_hsa00450 | -0.0516741 |
| 98 | Mineral absorption_Homo sapiens_hsa04978 | -0.0263519 |
| 99 | Amoebiasis_Homo sapiens_hsa05146 | -0.0202859 |
| 100 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0118947 |

